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Manchester Academic Health Science Centre, UKCell-matrix interactions and podocyte intercellular
junctions are key for maintaining the glomerular filtration
barrier. Vinculin, a cytoplasmic protein, couples actin
filaments to integrin-mediated cell-matrix adhesions and to
cadherin-based intercellular junctions. Here, we examined
the role of vinculin in podocytes by the generation of a
podocyte-specific knockout mouse. Mice lacking podocyte
vinculin had increased albuminuria and foot process
effacement following injury in vivo. Analysis of primary
podocytes isolated from the mutant mice revealed defects
in cell protrusions, altered focal adhesion size and
signaling, as well as impaired cell migration. Furthermore,
we found a marked mislocalization of the intercellular
junction protein zonula occludens-1. In kidney sections
from patients with focal segmental glomerulosclerosis,
minimal change disease and membranous nephropathy,
we observed dramatic differences in the expression levels
and localization of vinculin. Thus, our results suggest that
vinculin is necessary to maintain the integrity of the
glomerular filtration barrier by modulating podocyte foot
processes and stabilizing intercellular junctions.
Kidney International (2018) 93, 643–655; https://doi.org/10.1016/
j.kint.2017.09.021
KEYWORDS: cell adhesion; glomerular disease; glomerular filtration barrier;
podocyte; vinculin
Copyright ª 2017, International Society of Nephrology. Published by
Elsevier Inc. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).Correspondence: Shuta Ishibe, Section of Nephrology, Yale University School
of Medicine, PO Box 208029, 333 Cedar St, New Haven, CT 06520-8029.
E-mail: shuta.ishibe@yale.edu or Rachel Lennon or Christoph Ballestrem,
Wellcome Trust Centre for Cell-Matrix Research, Michael Smith Bldg,
University of Manchester, Manchester M13 9PT, UK. E-mail: Rachel.Lennon@
manchester.ac.uk or Christoph.Ballestrem@manchester.ac.uk
7FL and XT contributed equally to this article.
Received 10 May 2017; revised 23 August 2017; accepted 14 September
2017; published online 12 December 2017
Kidney International (2018) 93, 643–655T he glomerular filtration barrier is composed of highlyspecialized visceral epithelial cells (podocytes), theglomerular basement membrane (GBM), and fenes-
trated endothelial cells. The barrier prevents macromolecules
in the blood from traversing into the urine, and defects in the
barrier result in albuminuria and nephrotic syndrome. Recent
evidence has demonstrated the importance of cell–matrix
interactions in podocytes.1 These interactions are mediated by
cell surface integrin receptors binding to ligands in the GBM.
Human and mouse genetic studies have shown that ablation
or mutations in a3b1 integrin,2–4 along with its ligand, b2
laminin,5 result in severe proteinuria, and that genetic abla-
tion of integrin binding proteins—integrin linked kinase
(ILK),6 talin1,7 and tetraspanin CD1518—leads to phenoco-
pying of integrin loss, emphasizing the importance of cell–
matrix interactions for barrier function. Furthermore, the
integrity of the filtration barrier is also governed by the
podocyte slit diaphragm, a modified tight junction that
connects interdigitating foot processes, and serves as the
terminal barrier in the glomerulus.9 Patients harboring ge-
netic mutations in slit diaphragm proteins, such as nephrin,
FAT1, or podocin, present with severe, steroid-resistant
nephrotic syndrome.10
Vinculin is an adapter protein that localizes at cell–matrix
adhesions (also known as focal adhesions [FAs])11 and at cell–
cell junctions.12 It comprises an N-terminal head domain, a
proline-rich linker, and a C-terminal tail domain. The head
domain binds to talin at cell–matrix adhesions and pre-
dominantly to a-catenin at cell–cell junctions.13 The tail
domain has been shown to bind paxillin, F-actin, and phos-
phatidylinositol-4,5-bisphosphate.14–16 Vinculin has a well
characterized function of stabilizing cell–matrix adhesions by
orchestrating the recruitment and release of other cell–matrix
adhesion proteins, thereby controlling the strength of adhe-
sion binding to the extracellular matrix (ECM).17–19 Vinculin
also has been shown to regulate cell migration,20 which is
determined by the adhesive state of cells mediated by FAs and
their dynamic turnover.21 Although it is clear that vinculin
modulates cell adhesion, its role in the glomerular filtration
barrier is unclear.643
bas i c re sea r ch F Lausecker et al.: Vinculin required for glomerular functionAside from its function in cell–matrix adhesions, vinculin
is an important regulator of cell–cell junctions.22,23 Mice
lacking vinculin, specifically in cardiomyocytes, die suddenly
of ventricular arrhythmias due to disruption of gap junctions
containing intercalated disks at cell–cell junctions. If they
survive this early vulnerable period, such mice later succumb
to heart failure from a dilated cardiomyopathy, caused by
disruption of both cell–matrix and cell–cell junctions.24,25
Vinculin also is known to interact with zonula occludens
(ZO)-1 in the cardiac myocyte; with vinculin deficiency, an
associated reduction in ZO-1 occurs.25 The importance of
ZO-1 in the function of podocytes is best illustrated by Tjp1
(or ZO-1) knockout (KO) studies, as mice lacking this gene
develop severe proteinuria.26
Given that vinculin (Vcl) plays a pivotal role in regulating
cell–matrix and cell–cell adhesion, and that it binds ZO-1, we
hypothesized that it has a critical role in glomerular filtration.
To circumvent the embryonic lethality seen in the global Vcl
KO mouse,21 we generated a podocyte-specific Vcl KO mouse
using the Podocin-Cre and Vcl flox/flox system (Pod-Vcl-KO).
These mice were generally healthy, with only mild protein-
uria. However, Pod-Vcl-KO mice were more susceptible to
proteinuria and foot process effacement after injury. Isolated
Pod-Vcl-KO podocytes demonstrated an altered FA size,
increased phosphorylation levels of FA protein FAK, and
increased cell migration. Additionally, marked mislocalization
of the junctional protein ZO-1 occurred after injury. Finally,
in kidney biopsies from patients with focal segmental
glomerulosclerosis (FSGS), minimal change disease (MCD),
and membranous nephropathy (MN), marked differences
were found in vinculin localization that correlated with the
level of nephrin localization in capillary loops. Our findings
indicate that vinculin plays a critical role in maintaining the
glomerular barrier by regulating podocyte foot process
morphology and localizing ZO-1 at the plasma membrane.
RESULTS
Generation of the podocyte-specific Vcl-KO mouse
To study the role of vinculin in podocytes, we generated a
podocyte-specific vinculin KO mouse (Pod-Vcl-KO) using the
Cre–Lox system based on podocin cre, which is expressed at
E1427, and vinculin floxed transgenic mice24 (Figure 1a). The
Pod-Vcl-KO mice were born in the normal Mendelian fre-
quency as identified by tail genotyping (Figure 1b). Isolated,
enriched primary podocytes, harvested from the Pod-Vcl-KO
mouse and identified by the podocyte-specific marker Wilms
Tumor-1 (WT1), showed reduced vinculin expression, as
determined by western blot analysis (Figure 1c; quantified in
Figure 1d) and immunocytochemistry (Figure 1e). Kidneys
fromPod-Vcl-KOmice and control littermates (termed control
mice) were immunostained for vinculin and the podocyte-
specific marker nephrin, which confirmed that the observed
loss of vinculin was podocyte specific, as co-localization of the
markers was lost in the Pod-Vcl-KO (Figure 1f). In summary
these data demonstrate the successful elimination of vinculin
from podocytes in the Pod-Vcl-KO mouse.644Vinculin is required for podocyte integrity after injury
As evidence of the rigorous and reproducible results from this
animal model, Pod-Vcl-KO mice were generated indepen-
dently in our two laboratories, and most (approximately
90%) of the mice were normal (studied to age 10 months).
No differences were observed between Pod-Vcl-KO and
control mice, with respect to kidney morphometry (weight or
size) (Supplementary Figure 1A; quantified in Supplementary
Figure 1B), nor was there evidence of alteration in serum
creatinine levels in the Pod-Vcl-KO (data not shown). Renal
histology demonstrated normal glomerular architecture, with
no evidence of fibrosis compared with age-matched control
mice (Figure 2a). A total of 38% of aged Pod-Vcl-KO mice
(age $9 months) kidneys had large glomerular cysts
(Supplementary Figure 1C). These cysts were not observed in
any of the younger Pod-Vcl-KO mice.
Given that basal findings of the Pod-Vcl-KO mice showed
only minor abnormalities, we next challenged these mice by
administering rabbit anti-mouse GBM (nephrotoxic serum
[NTS]). At 7 days after NTS injection, the Pod-Vcl-KO mice
exhibited glomerular damage characterized by increased
mesangial matrix accumulation (Figure 2b). Transmission
electron microscopy (TEM) revealed more foot process
effacement in the Pod-Vcl-KO mice treated with NTS,
compared with control mice (Figure 2c). Quantification of
mesangial matrix accumulation and foot process effacement
reveals significant differences between NTS-treated Pod-Vcl-
KO mice and control mice treated with NTS (Figure 2d
and e). We also challenged the mice with i.p. lipopolysac-
charide (LPS), which is considered to be an animal model for
minimal change disease, and we observed no histologic dif-
ferences using light microscopy (Figure 2b; quantified in
Figure 2d). Ultrastructural examination by TEM showed an
increase in podocyte injury, as evidenced by foot process
effacement in the Pod-Vcl-KO compared with control mice
(Figure 2c; quantified in Figure 2e). Lastly, functional analysis
demonstrated that after either NTS- or LPS-induced
glomerular injury, the Pod-Vcl-KO mice had significantly
more albuminuria compared with age-matched control mice
treated with the same agents at various time points (Figure 2f
and g). Together, these findings indicate that Pod-Vcl-KO
mice are more susceptible to glomerular injury.
The loss of vinculin alters podocyte foot process morphology
Podocytes form long, interdigitating foot processes in vivo,
and these are indispensable for intact barrier function. To
investigate whether vinculin plays a role in the regulation of
podocyte morphology, we examined the number and length
of podocyte foot processes in Pod-Vcl-KO mice in vivo, per-
forming serial block-face scanning electron microscopy
(SBFSEM). Feature tracking of intact podocytes revealed the
complex morphology of these cells (Supplementary
Figure S2A and Supplementary Movie S1). In contrast to
control podocytes, we found that Pod-Vcl-KO podocytes had
smaller cell bodies, with a branching phenotype in which
processes merged soon after branching occurred (Figure 3a,Kidney International (2018) 93, 643–655
Figure 1 | Generation of podocyte-specific Vcl-KOmice. Schematic demonstrating the breeding of the Podocin-Cre mice with Vclflow/flow mice
to generate the podocyte-specific Vcl-KO mice (Pod-Vcl-KO; a). Identification of Vclfl/fl and Podocin-Cre by tail genotyping (b). Representative
vinculin protein level in purified control (Ctrl) podocytes and loss of immunoreactivity of vinculin in podocytes harvested from Pod-Vcl-KO mice
as detected by Western blotting; n ¼ 3 independent experiments (c). Quantification of vinculin protein levels relative to WT1 protein levels:
N ¼ 5; *P < 0.001 (d). Localization of vinculin and wild type (WT)1 in control and Pod-Vcl-KO primary podocytes by immunofluorescence (bar ¼
10 mm; e). Double immunofluorescence of nephrin and vinculin on kidney sections of the indicated genotypes (f). In the merged image, vinculin
is shown in green; nephrin is shown in the red channel (bar ¼ 10 mm). To optimize viewing of this image, please see the online version of this
article at www.kidney-international.org.
F Lausecker et al.: Vinculin required for glomerular function bas i c re sea r chwhite arrowhead; Supplementary Movies S2 and S3).
Although the average length of the major protrusions was not
different (Figure 3b), foot process length was significantly
increased in Pod-Vcl-KO podocytes compared with control
cells (Figure 3b, yellow arrowhead; quantified in Figure 3c).
This increase in foot process length and the branching
phenotype was exacerbated upon treatment with NTS
(Supplementary Figure S2B–D). These data reveal that vin-
culin is required for maintenance of normal cellular pro-
trusions and foot processes in the podocyte.
Loss of vinculin increases FAK tyrosine phosphorylation in
podocyte focal adhesions
Vinculin is a known component of the consensus adhesome28
and plays a critical role in signal transduction from FAs3 to
the actin cytoskeleton.29,30 To investigate the role of vinculin
in the regulation of podocyte FAs, we analyzed control and
Pod-Vcl-KO podocytes, cultured on the GBM substrate
collagen IV. Paxillin immunofluorescence revealed that the
FAs of nephrin-positive control podocytes had an average areaKidney International (2018) 93, 643–655of 5 mm2, whereas those from Pod-Vcl-KO podocytes were
significantly smaller, with an average size of 3 mm2 (Figure 4a;
quantified in Figure 4b). Western blotting analysis revealed no
differences in total cellular expression levels of FA proteins
between control and Pod-Vcl-KO podocytes (Supplementary
Figure S3A). Next, we examined whether the decreased FA
size in Pod-Vcl-KO podocytes was associated with altered FA
signaling, by comparing the ratio of phosphorylated FAK
(pFAK) at tyrosine 397 to endogenous paxillin in Pod-Vcl-KO
podocytes and control podocytes, using ratiometric imag-
ing.31 These images revealed increased pFAK to paxillin levels
in Pod-Vcl-KO podocytes, compared with ratios in control
podocytes (Figure 4c; Supplementary Figure S3B). The total
cellular protein levels of pFAK remained unchanged in Pod-
Vcl-KO podocytes (Supplementary Figure S3A), highlighting
the fact that vinculin-dependent FAK phosphorylation and
signaling is site-specific.
Both vinculin and FAK have been shown to regulate the
strength of adhesion of cells to ECM.32,33 To investigate
whether vinculin regulates adhesion strength in podocytes, we645
Figure 2 | Loss of Vcl in podocytes results in worsened albuminuria and foot process effacement. Representative light microscopy images
of glomeruli from control and Pod-Vcl-KO mice at age 8 weeks, stained with hematoxylin and eosin (H&E), periodic acid–Schiff (PAS), and
Trichrome (Tri), which reveal no significant differences (bar ¼ 20 mm; a). Representative images of control (Ctrl) and Pod-Vcl-KO mice at age 8
weeks after nephrotoxic serum (NTS) injection at 7 days and lipopolysaccharide (LPS) treatment after 24 hours (bar ¼ 20 mm; b). Transmission
electron micrographs revealing foot process effacement in Ctrl and Pod-Vcl-KO mice after LPS treatment (24 hours) and NTS injection (7 days)
(bar ¼ 150 nm; c). Quantification of (b); mesangial expansion was assessed with a score from 0 to 4, with 0 representing no detectable
mesanigal expansion, and 4 being severe, by blinded pathologist. A total of 15–20 glomeruli were analyzed from n ¼ 4 mice; *P < 0.01 (d).
Quantification of (c), the number of foot processes per micrometer of glomerular basement membrane in the Ctrl and Pod-Vcl-KO mice after
NTS or LPS injection. N ¼ 3 mice were used at each time point. *P < 0.001 (e). Quantification of urinary albumin normalized to creatinine at 0, 1,
7, 14, and 28 days after NTS. N ¼ 10 mice at each time point; *P < 0.001. Error bars show SEM (f). Quantification of urinary albumin normalized
to creatinine at 0, 12, 24, 48, and 72 hours after LPS treatment. N ¼ 10 mice at each time point; *P < 0.001. Error bars show SEM (g). To optimize
viewing of this image, please see the online version of this article at www.kidney-international.org.
bas i c re sea r ch F Lausecker et al.: Vinculin required for glomerular function
646 Kidney International (2018) 93, 643–655
Figure 3 | Podocytes from Pod-Vcl-KO mice showed altered morphology of cellular protrusions in vivo. 3View tracking of podocytes
in vivo using serial block face scanning electron microscopy. White arrowhead highlights the rejoining of cellular protrusions. Yellow arrow-
heads highlight the foot process lengths. Bar ¼ 10 um in the bigger images on the left, and 1 um in smaller images on the right (a). Length of
major protrusions was measured within the modeled podocyte from the first branching point of the cell body to the final tip; n ¼ 5 protrusions
per cell; 3 podocytes from different animals were analyzed (b). Foot process length was measured from the last branching point to the end of
the foot process (N ¼ 60 processes per cell, N ¼ 3 mice). *P < 0.001 based on a Student’s t-test (c). To optimize viewing of this image, please see
the online version of this article at www.kidney-international.org.
F Lausecker et al.: Vinculin required for glomerular function bas i c re sea r chperformed adhesion assays, plating Pod-Vcl-KO and control
podocytes on collagen I, laminin, and fibronectin. Regardless
of the substrate, no significant difference in adhesion was
detected between control and Pod-Vcl-KO podocytes
(Figure 4d). Signals from FAs control a diverse repertoire of
cellular functions, such as migration and proliferation.21,34
Vinculin, as well as FAK, has been shown to influence the
motile behavior of cells.32,35 Therefore, to investigate whether
vinculin affects podocyte cell migration, we performed a
wounding assay using electrical cell-substrate impedance
sensing. In this assay, the transepithelial resistance of a cell
monolayer against an applied current is measured. Inducing a
wound to the cell monolayer by applying a high current
locally induces cell death in a defined area. The induced
wound led to a rapid drop in transepithelial resistance, which
was followed by an increase in resistance as cells migrated and
repopulated the gap. Filling the gap resulted in a resistance
plateau when the epithelial barrier was fully re-established
(Supplementary Figure S3C). Pod-Vcl-KO podocytes
showed decreased half-times following the rise of resistance
after wounding (Figure 4e), indicating faster migration
compared with control podocytes.
Loss of vinculin impairs podocyte mechanosensing
The kidney is a force-loaded organ, requiring appropriate
mechanosensing to facilitate normal filtration. FAs are critical
for sensing of external stimuli, and vinculin has been pro-
posed to have a key role in this process. To investigate the
extent to which vinculin is involved in sensing and adapting
to varying forces in podocytes, we performed force-sensing
assays whereby immortalized human podocytes, transfectedKidney International (2018) 93, 643–655with small interfering (si)RNA targeting vinculin, were seeded
on flexible polydimethylsiloxane (PDMS) membranes and
exposed to cyclic stretching for 25 minutes (10% strain at 1
Hz). Cellular responses were recorded, and the cellular re-
orientation with respect to the direction of stretch was
analyzed (Supplementary Figure S3D) by measuring the
cosine of the measured angle (Figure 4f). Measurements
revealed that podocytes transfected with scrambled siRNA
(siCtrl) re-organized perpendicular to the stretch axis, as has
been reported for other cell types36 (Figure 4g). Podocytes
transfected with siRNA targeting vinculin (siVcl)
(Supplementary Figure S3E) resulted in a significantly
reduced ability to respond to stretching forces (Figure 4g).
From these data, we conclude that vinculin plays an impor-
tant role in the response of podocytes to stretching forces.
ZO-1 localization at cell–cell junctions is impaired in Pod-Vcl-
KO podocytes after injury
As vinculin also plays an important role at sites other than
FAs, we next examined how vinculin modulates intercellular
adhesions. Given that ZO-1, a tight junction protein, has been
shown to be required in podocyte health, and to interact with
vinculin, we investigated whether vinculin helps to properly
localize ZO-1. Using immunofluorescence, we found that
vinculin co-localizes with ZO-1 both in vivo and in vitro
(Figure 5a, white arrowhead). Vinculin co-localization was
not found along the entire length of intercellular junctions
but rather at discrete contact areas between two cells
(Figure 5a, white arrowhead, lower panel). Additionally,
vinculin immunoprecipitation revealed binding of ZO-1 to
vinculin in control podocytes (Supplementary Figure S4A).647
Figure 4 | Loss of vinculin impairs focal adhesion (FA) signaling. Podocytes were isolated from control (Ctrl) and Pod-Vcl-KO mice and
stained for paxillin. Nephrin staining was used to verify podocyte cell identity. Note that the FAs in Ctrl podocytes are bigger than those in
vinculin-deficient podocytes (a). FA size was quantified by drawing around the adhesions and measuring the area in ImageJ. A total of 20–25
adhesions were analyzed, from 60 cells, in 3 independent experiments. *P < 0.001 (b). Phospho FAK (Y397) to paxillin levels were calculated
performing ratio imaging. Focal adhesions were analyzed from 60 cells, in 3 independent experiments; *P < 0.01 (c). Adhesions assays, using
crystal violet, were performed with Pod-Vcl-KO and Ctrl podocytes plated on collagen I, laminin, and fibronectin. Optical density (OD) was
measured at 595 nm. N ¼ 3 for each substrate (d). To investigate cellular migration, we performed a wounding assay using electrical cell
substrate impedance sensing (ECIS), in which cells forming a cell monolayer insulate against an applied current. The left image shows a
nonlinear regression of the increase in resistance after wounding. Half-time was calculated to compare migratory behavior of podocytes, filling
the induced wound. The right graph shows quantified half-times. N ¼ 18, pooled from 4 independent experiments (e). Cellular orientation of
immortalized human podocytes was analyzed by calculating the cosine of the angle of cellular orientation regarding the direction of stretch.
Cosine (angle) ¼ 0.5 represents random cellular organization; cosine (angle) ¼ 1 demonstrates perpendicular orientation toward the stretch
direction, whereas cosine (angle) ¼ 0 implies a parallel organization of the cells (f). Small interfering (si)RNA–mediated knockdown of vinculin
and control knockdown using scrambled siRNA was induced in human immortalized podocytes, and the cosine of the angle was calculated.
N ¼ 300 from 3 independent experiments; *P < 0.05 (g). To optimize viewing of this image, please see the online version of this article at www.
kidney-international.org.
bas i c re sea r ch F Lausecker et al.: Vinculin required for glomerular functionTo gain further insight into the potential role of vinculin in
the regulation of these intercellular junctions, their integrity
was determined by the localization of ZO-1 at cell–cell ad-
hesions of Pod-Vcl-KO and control podocytes that were
injured with either LPS or protamine sulfate (PS) stimulation.
Quantitative immunofluorescence staining of primary podo-
cytes stimulated with LPS or PS revealed an increased abun-
dance of ZO-1 localization in the cytoplasm of Pod-Vcl-KO
podocytes, in comparison with control podocytes (Figure 5b;
quantified in Figure 5c; Supplementary Figure S4B.) Addi-
tionally, cell fractionation revealed significantly pronounced
ZO-1 redistribution from the membrane to the cytoplasm
after LPS- or PS-induced injury in Pod-Vcl-KO podocytes,648compared with control podocytes (Figure 5d; quantified in
Figure 5e). Further validating our findings, in vivo, podocytes
isolated from Pod-Vcl-KO and control mice that were injected
with either LPS or NTS revealed a significantly increased
presence of ZO-1 in the cytoplasm of Pod-Vcl-KO, compared
with control podocytes (Figure 5f; quantified in Figure 5g).
To further confirm the role of vinculin in stabilizing
intercellular adhesions in podocytes, we performed rescue
experiments and re-expressed vinculin into Pod-Vcl-KO
podocytes. Our results reveal that expression of green fluo-
rescent protein–vinculin in Pod-Vcl-KO podocytes partially
restored ZO-1 localization at cell–cell junctions even after
podocyte injury. Quantification showed a 25% reduction ofKidney International (2018) 93, 643–655
F Lausecker et al.: Vinculin required for glomerular function bas i c re sea r chZO-1 intensity in the cytoplasm of rescued cells in compar-
ison with untransfected Pod-Vcl-KO podocytes treated with
LPS or PS (Figure 6a; quantified in Figure 6b). Taken together,
these experiments reveal that vinculin is pivotal in stabilizing
cell–cell adhesions in podocytes after glomerular injury.
Vinculin levels are altered in human glomerular disease
To investigate the importance of vinculin in human disease
processes, we analyzed kidney biopsy sections from patients
who had FSGS, MCD, or MN, and compared them to healthy
control tissue. The localization of nephrin was similar in
control and MCD sections and showed an even distribution
across glomeruli (Figure 7a). In contrast, the localization of
nephrin in MN and FSGS samples was more focal and
punctate, and regions of reduced nephrin expression had
increased ECM deposition (Supplementary Figure S5). Vin-
culin localized to nephrin-positive capillary loops in all
analyzed disease cases (Figure 7a, white boxes). However, in
FSGS, we detected reduced vinculin localization to nephrin-
positive capillary loops, compared with capillary loops, with
reduced nephrin staining (Figure 7a—compare white and
yellow boxes). To analyze overall vinculin localization to
capillary loops in glomerular diseases, we performed ratio-
metric imaging, quantifying vinculin levels relative to nephrin
levels specifically in nephrin-positive areas (Figure 7b). The
blue-colored nephrin-positive masks, in both FSGS and MN
sections, indicate a low vinculin-to-nephrin ratio, whereas in
control and MCD sections, we detected red/white color pat-
terns, indicating a higher vinculin-to-nephrin ratio in these
glomeruli (Figure 7b; quantified in Figure 7c). Taken together,
these data demonstrate that with human glomerular disease,
marked differences are present in the level and localization of
vinculin.
DISCUSSION
Vinculin is known as a mechanosensitive regulator of cell–
matrix adhesions and cell–cell junctions. In this study, we
found that vinculin has a role in maintaining podocyte barrier
integrity both in vivo and in vitro. We report the following: (i)
Pod-Vcl-KO mice develop proteinuria upon challenge; (ii)
defects in podocyte cell protrusion/foot process morphology
occur in Pod-Vcl-KO mice; (iii) altered adhesion signaling
with impaired FAK phosphorylation occurs in Pod-Vcl-KO
podocytes; (iv) disrupted intercellular junctions with
mislocalization of the key junctional protein ZO-1 are detected
in Pod-Vcl-KO podocytes; and (v) analysis of human kidney
sections revealed that vinculin localization is altered in
glomeruli of FSGS, MCD, and MN samples, compared with
control samples. Overall, our findings highlight the importance
of vinculin in the regulation of the glomerular filtration barrier
in response to injury in both mouse and human kidneys.
Vinculin is a core component of the FA protein complex,
where it is exposed to tension.15 In this study, we show that
vinculin is a critical regulator of tension-sensing in podocytes;
vinculin-deficient podocytes showed a significant decrease in
ability to respond to cyclic stretching. These data are inKidney International (2018) 93, 643–655keeping with studies in fibroblasts showing that vinculin (and
its link to the actin cytoskeleton) is important for not only
sensing of stretching forces30 but also transduction of forces
in FAs.20,37,38 In addition to mechanotransduction, vinculin
controls adhesion signaling by coordinating adhesion
signaling proteins.30 This ability largely depends on its inti-
mate relationship with talin,39,40 which also is required to
maintain glomerular barrier integrity; podocyte-specific KO
of talin 1 causes severe glomerular dysfunction and early
kidney failure.7 FAK is also a core constituent of FAs, binding
to talin41 and regulating FA turnover.42,43 In this study, we
found that FAK phosphorylation (Y397) is increased in FAs of
Pod-Vcl-KO podocytes (Figure 4c). This increase in FAK
phosphorylation may explain the increase we observed in cell
motility in Pod-Vcl-KO podocytes, because increased FAK
phosphorylation (in conjunction with Src and paxillin
phosphorylation) has been associated with an increase in
protrusive activity44 through increased Rac1 activity.45,46
We observed significant differences in the organization of
cellular protrusions between Pod-Vcl- KO and control
podocytes in vivo, in which we observed an increased number
of foot processes in Pod-Vcl-KO podocytes. This highlights
the role of vinculin in the organization of the actin-dependent
cellular extensions. Furthermore, LPS/PS-induced injuries
in vivo were associated with more proteinuria in the Pod-Vcl-
KO, compared with control mice expressing vinculin, sug-
gesting its importance in maintaining the integrity of the
barrier function.
Vinculin not only controls FA stability, but also regulates
cell–cell adhesions.12 In epithelial cells, vinculin localization to
cell–cell junctions is driven in a force-dependent manner.47
Considering the consistently high transcapillary pressure that
podocytes endure as they encounter 180L of plasma daily, we
suggest that vinculin functions in a force-dependent way in
podocytes, where its recruitment helps to maintain the integ-
rity of the glomerular filtration barrier. In this regard, the mild
phenotype observed in the Pod-Vcl-KO mice was initially
surprising. This finding suggests that vinculin is dispensable
during development of the kidney but plays a more important
role at later stages, or when the kidney is challenged and needs
to recover after (or be protected from) injury. This possibility is
in line with our observations showing that defects in barrier
function become more evident upon challenge with LPS and
NTS (Figure 2e and f). This hypothesis is also consistent with
reports showing that cells are able to form cell–matrix adhe-
sions and cell–cell junctions in the absence of vinculin and that
deficiencies in cellular responses become evident only upon
challenge (e.g., application of forces).30,47,48 In addition, we
found that 38% of aged mice had large glomerular cysts. Cystic
kidney disease is associated with a growing number of muta-
tions in the components of primary cilia. Glomerulocystic
disease overlaps with this disease spectrum, and the absence of
vinculinmay be relevant for normalmechanosensing of flow in
the glomerulus in aged mice.
Intercellular junctions are critical for the maintenance of
glomerular filtration,49 and we detected decreased glomerular649
Figure 5 | Loss of Vcl in podocytes results in the redistribution of adherens junction protein zonula occludens (ZO)-1 to the cytosol.
Vinculin colocalizes with ZO-1 at cell–cell junctions (arrow) in wild-type mouse kidney tissue at age 8 weeks, and in primary podocytes
(arrowheads) isolated from wild-type mice (a). Lipopolysaccharide (LPS) or protamine sulfate (PS) treatment in Pod-Vcl-KO podocytes results in
an increase in cytosolic ZO-1, compared with control (Ctrl) podocytes. Arrowheads depict mislocalization of ZO-1 in Pod-Vcl-KO podocytes.
Bar ¼ 10 mm (b). Quantification of the distribution of ZO-1 by fluorescence intensity; n ¼ 3; *P < 0.05; intensity was normalized to untreated
conditions (c). Treatment with LPS or PS results in relocalization of ZO-1 to the cytosolic fraction in podocytes that lack vinculin (d). Quanti-
fication by densitometry of (d); n ¼ 5; *P < 0.01 (e). Western blot of membrane and cytosolic fractions from podocytes isolated from (continued)
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Figure 6 | Re-expression of green fluorescent protein (GFP)–Vcl in Pod-Vcl-KO podocytes rescues zonula occludens (ZO)-1
mislocalization after either lipopolysaccharide (LPS) or protamine sulfate (PS) treatment. Representative image of Pod-Vcl-KO primary
podocytes re-expressing GFP-vinculin shows that zonula occludens (ZO)-1 is at the cell–cell junctions, and this persists after the LPS challenge
(white arrowheads). Note the ZO-1 mislocalization in adjacent, untransfected Pod-Vcl-KO podocytes serving as an internal control (arrowhead).
Bar ¼ 10 mm. GFP alone transfection was also performed as a control (ctrl). Note that the bottom panel stimulated with LPS is at x100 (a).
Quantitative analysis of the redistribution of ZO-1 is represented by comparing the cytoplasmic to the total cellular immunofluorescence in-
tensity after either LPS or PS treatment in mouse GFP–vinculin expressing and nonexpressing primary podocytes; n ¼ 3; *P < 0.05 (b). To
optimize viewing of this image, please see the online version of this article at www.kidney-international.org.
=
Figure 5 | (continued) Ctrl and Pod-Vcl-KO mice after treatment (in vivo) with LPS or NTS (f). Quantification by densitometry of (f); n ¼ 5; *P <
0.01. Intensity was normalized to untreated conditions (g). C, cytoplasm; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; M, membrane;
NTS, nephrotoxic serum. To optimize viewing of this image, please see the online version of this article at www.kidney-international.org.
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F Lausecker et al.: Vinculin required for glomerular function bas i c re sea r chbarrier function upon glomerular injury in Pod-Vcl-KO mice
(Figure 2), suggesting that vinculin contributes to these junc-
tions in podocytes. The junctional protein ZO-1 appears to
have a particular role in the cell–cell junctional mediated bar-
rier function, as our data show that in Pod-Vcl-KO podocytes,
ZO-1, upon induction of injury, fails to localize to intercellular
junctions, a phenotype that can be rescued by the re-expression
of vinculin in these cells (Figure 6). The regulatory effect in
cell–cell adhesions would be in line with other reports, inwhich
vinculin was found to have a role in the communication be-
tween cells by binding to ZO-1, thus stabilizing gap junction
formation.25 Podocyte-specific loss of ZO-1 in mice results in
severe proteinuria, foot process effacement, and glomerulo-
sclerosis.26 Hence, the altered localization of ZO-1 in our ex-
periments could be a factor in the reduction of barrier function
after LPS and NTS challenge (Figure 5). The significance of
vinculin localization to specific areas along a cell–cell contact in
podocytes is yet to be determined, but it could represent a
contribution to an “adhesion zipper,” previously described as
an initial step in adherens junction formation of keratino-
cytes.50 Additional experiments are needed to test this model
and further dissect the mechanism by which vinculin con-
tributes to glomerular barrier function.
In conclusion, we report that vinculin has a key role in the
regulation of podocyte-mediated glomerular filtration. Our
data suggest that vinculin has a protective function and is
important for maintenance of the barrier function after injury.
This model is in line with our data from human biopsies
demonstrating that vinculin localization is altered in glomer-
ular disease. With the advent of whole-exome and whole-
genome sequencing across an ever-increasing number of
clinical cohorts with kidney disease, genetic variants in vinculin
may shed further light on the role of vinculin in human disease.CONCISE METHODS
Mice
Podocin-Cre recombinase mice were obtained from the Jackson
Laboratory, Bar Harbor, Maine (B6.Cg-Tg(NPHS2-Cre)295Lbh/J,
stock number 008205). The mice carrying the floxed vinculin
construct were obtained from Robert Ross, University of California,
San Diego.24 Analyzed Pod-Vcl-KO and control littermate mice were
on a C57/Bl6 background, which is relatively resistant to glomerular
disease. Urine samples were collected from the Pod-Vcl-KO and
littermate Vcl fl/fl controls at indicated time.
NTS and LPS treatment
Treatment of mice with rabbit anti-mouse GBM antibody (NTS),
generated by Lampire Biological Laboratories, was performed as=
Figure 7 | Vinculin is reduced in human glomerular disease. Panels
sections from patients with focal segmental glomerulosclerosis (FSGS),
The altered localization of vinculin and nephrin is shown in zoomed-in
there appeared to be less vinculin in capillary loops with positive neph
reduced, and here vinculin was increased (yellow boxes). Bar ¼ 20 mm
signal as a mask and then relating vinculin to nephrin intensity. Bar ¼
analyzed from n ¼ 3 biopsy samples. *P < 0.001 (c). To optimize viewin
kidney-international.org.
Kidney International (2018) 93, 643–655previously described in our laboratory.7,51 Briefly, mice were pre-
immunized 6 days prior to administration of NTS, via i.p. injection
of 250 mg of rabbit IgG (Jackson Immunoresearch Laboratories, Bar
Harbor, ME) in 250 ml of 1:1 emulsion with complete Freund’s
adjuvant (Sigma-Aldrich, St Louis, MO). Glomerulonephritis was
induced with 200 mg of NTS using retro-orbital injection as previ-
ously described.7,51 Preimmune rabbit serum was used as a negative
control. For the LPS-induced animal model, mice were given an i.p.
injection either with or without LPS (10 mg/g body weight, 1mg/ml
in sterile phosphate buffered saline). Animal perfusions with 4%
paraformaldehyde (PFA) were carried out as previously described.51
Pod-Vcl-KO mice and control mice (age 6 to 8 weeks) were used for
these experiments. Urinary albumin excretion was measured at
various time points.
Electron microscopy
As previously described,52 we used transmission electron microscopy
(TEM) and serial block-face scanning EM (SBF-SEM) to investigate
glomerular ultrastructure. Tissue samples were fixed for at least 1 hour
in a mix of 2% formaldehyde and 2.5% glutaraldehyde in 0.1 M so-
dium cacodylate buffer (pH 7.4). The samples were post-fixed with
reduced osmium (1% OsO4 and 1.5% K4Fe(CN)6) for 1 hour, then
with 1% tannic acid in 0.1M sodium cacodylate buffer for 1 hour, and
finally with 1% uranyl acetate in water overnight. The specimens were
dehydrated with alcohols, infiltrated with resin (TAAB LV, Taab Lab-
oratories, Reading, United Kingdom), and polymerized for 12 hours at
60  C. Ultrathin 70-nm sections were cut with a Leica Ultracut S
ultramicrotome (Leica, Wetzlar, Germany) and placed on formvar/
carbon-coated slot grids. The grids were observed in a Tecnai 12
Biotwin transmission electron microscope (ThermoFisher Scientific,
Waltham, MA) at 80 kV. EM data were screened for matrix charac-
teristics using Fiji/ImageJ software (version 1.46r; National Institutes
of Health, Bethesda, MD). GBM thickness was quantified in five re-
gions per observation and reported as mean values. For SBF-SEM, the
polymerized samples were trimmed, glued to aluminum pins, and
sputter coated with gold/palladium (60 seconds at standard settings).
Automated sectioning (60 nm) was completed in a Gatan 3View
(Gatan Inc, Pleasanton, CA). The images were taken with FEI Quanta
250 FEG SEM (ThermoFisher Scientific) at 3.8kVaccelerating voltage
and 0.4 Torr chamber pressure, with a pixel size of 12 nm.Models were
generated fromSBF-SEMusing IMOD3Dmod software (http://bio3d.
colorado.edu/imod/download.html.), developed by David Mas-
tronade and coworkers at the Boulder (CO) Laboratory for 3-D
Electron Microscopy.
Study approval
All animal experiments were approved by the relevant institutional
regulatory board as follows: the University Committee on the Use
and Care of Animals Institutional Review Board approved work at
Yale University, and all work was conducted in accordance with the
principles and procedures outlined in the National Institutes of
Health Guide for the Care and Use of Laboratory Animals (8thshow localization of nephrin and vinculin in human kidney biopsy
minimal change disease (MCD), or membranous nephropathy (MN).
images at the bottom of the panel. In FSGS and MN in particular,
rin staining, compared with regions where nephrin localization was
(a). Ratiometric imaging was performed by selecting the nephrin
30 mm (b). Quantification of (b): All histological subtypes were
g of this image, please see the online version of this article at www.
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reviewed and approved by the University of Manchester Animal
Welfare and Ethical Review Board, and all procedures were carried
out in accordance with the European Directive 2010/63/EU governed
by the Home office in the United Kingdom. Ethical approval was
obtained to use archival pediatric biopsy samples (REC reference:
14/WA/0083), normal human tissue, and archival adult biopsy
samples (REC reference: 16/NW/0119).
Statistical analysis
All measurements are shown as mean  SEM. Box plots indicate
maximum and minimum data points (whiskers). Bar chart error
bars represent SEM. Statistical analysis was performed using 2-tailed
Student’s t-test or 1-way analysis of variance (SigmaStat, version
3.1.1). P < 0.05 was considered statistically significant.
Antibodies and reagents and all other methodology are described
in the Supplemental Experimental Procedures.
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Supplemental Experimental Procedures. Antibodies and reagents,
urinary albumin and creatinine quantification, isolation of murine
glomeruli and cell culture, knockdown experiments, Electric Cell-
substrate Impedance Sensing (ECIS), measurement of albumin flux,
stretching assay, analysis of membrane to cytosol transfer of ZO-1,
Western blotting, PCR, quantification of the number of foot processes
from electron micrographs, immunofluorescence, ratiometric imaging
analysis, and immunoprecipitation.
Figure S1. Kidney abnormalities are detected in mice of advanced
age. Most kidneys from Vcl KO and control (Ctrl) mice did not a reveal
a morphologic difference (A). Kidney weight (g) was analyzed relative
to kidney size (cm) (B). Hematoxylin and eosin staining of Pod-Vcl-KO
mice shows sporadic cystic abnormalities. Left image shows multiple
cysts within the kidney of a Pod-Vcl-KO mouse. The bar ¼ 2 mm. The
middle image shows cystic abnormalities within the glomerular
Bowman’s capsule. Bar ¼ 200 mm. The right image shows
crystallization of protein in tubular structures. Bar ¼ 100 mm (C).
Figure S2. 3View serial block-face scanning electron microscopy
(SEM). Generation of a 3-dimensional model of podocytes using serial
block-face SEM (A). 3D models of control (Ctrl) and Pod-Vcl-KO654podocytes after challenge with nephrotoxic serum (NTS). White
arrowhead highlights the branching defect, and the yellow arrow-
head shows the difference in length of the foot processes. Note the
branching defect in the ctrl podocytes after treatment with NTS (B).
Quantification of major protrusion length (C). Quantification of foot
process length; N ¼ 3 cells modeled from different animals (D).
Figure S3. Vinculin deficiency increases phospho–focal adhesion
kinase (pFAK) levels specifically at focal adhesions (FAs). Primary
podocytes were isolated from control and Pod-Vcl-KO mice and
treated with lipopolysaccharide (LPS) and protamine sulfate (PS).
Western blot was performed to determine protein levels of FA
proteins, vinculin, talin1, FAK, paxillin, pFAK, phospho-Paxillin (pPax-
ilin), and the housekeeping gene glyceraldehyde 3-phosphate de-
hydrogenase (GAPDH; A). Immunofluoresecence ratio imaging was
performed to determine phopho-FAK levels relative to paxillin protein
levels specifically at FAs. Line profile highlights elevated phospho-FAK
levels to paxillin levels at FAs in podocytes isolated from Pod-Vcl-KO
mice compared to control (Ctrl) podocytes (B). Schematic illustration
of a wounding assay: A single electrical cell substrate impedance
sensing (ECIS) well carries 10 electrodes, where resistance is
measured. Following cell plating, resistance increases (1.) and finally
plateaus (2.) when cells form a monolayer. Cells located on the
electrode are wounded by application of a high current, leading to
local cell death and a drop in resistance (3.). Increased migration and
proliferation result in increasing resistance (4.). When a confluent cell
monolayer is re-established, resistance plateaus (5.). The lower graph
shows a representative curve progression of the ECIS resistance
measurement, including a wounding assay (C). Schematic demon-
stration of the analysis of the stretching assay: After application of the
stretching cycles, cells were fixed and stained with 40,6-diamidino-2-
phenylindole DAPI and phalloidin. An ellipse was constructed into the
cells, and the angle was measured using ImagJ (D). Small interfering
(si)RNA-induced knockdown of vinculin was verified using western
blot analysis (E). a-tubulin was used as loading control. Upon stretch
application, cells organize themselves so that they are perpendicular
to the direction of stretch.
Figure S4. Vinculin controls zonula occludens (ZO)-1 localization
upon injury. Co- immunoprecipitation of control and Pod-Vcl-KO
podocytes shows vinculin association with ZO-1 in controls (ctrl), but
not in IgG or vinculin KO podocytes (A). Representative XY and XZ
images show that ZO-1- colocalization with membrane marker
E-cadherin is reduced in Pod-Vcl-KO podocytes after lipopolysaccha-
ride (LPS) and protamine sulfate (PS) stimulation (B).
Figure S5. Membranous nephropathy (MN) and focal segmental
glomerulosclerosis (FSGS) sections show altered hematoxylin and
eosin (H&E) and nephrin staining. Serial sections from patients with
MN, minimal change disease (MCD), and FSGS were stained for H&E
and in parallel for nephrin and vinculin. Bar ¼ 20 mm (A).
Movie S1. Modeling of podocytes in vivo. Three adjacent podocytes
from a control mouse were modeled from 800 sections captured by
serial block-face scanning electron microscopy. The movie illustrates
the complex cellular architecture of podocytes and their interdigi-
tating foot processes.
Movie S2. Control podocyte. Serial block-face scanning electron
microscopy and modeling were used to generate this 3D model of a
control podocyte. It demonstrates the branch hierarchy of the cell
body, from major protrusions to fine foot processes.
Movie S3. Podocyte-Vcl-knockout (Pod-Vcl-KO) podocyte. Serial
block-face scanning electron microscopy and modeling were used to
generate this 3D model of a Pod-Vcl-KO podocyte. Defects were
detected in the branching of major protrusions, and foot processes
appeared longer in the KO podocytes than in control cells.
Supplementary material is linked to the online version of the paper at
www.kidney-international.org.Kidney International (2018) 93, 643–655
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